IVIEW Therapeutics Secures Series A++ Funding for Ophthalmology Pipeline
IVIEW Therapeutics Inc., an ophthalmology biotech operating out of the US and China, has reportedly...
Deals
Daiichi Sankyo Acquires Gatipotuzumab IP Rights for $132.5M
Japan-based Daiichi Sankyo Company, Ltd (TYO: 4568) has announced an investment of USD 132.5 million...
a16z Bio + Health Launches Biotech Ecosystem Venture Fund
Andreessen Horowitz (a16z) Bio + Health has announced the establishment of the Biotech Ecosystem Venture...
Fujian Haixi Pharmaceuticals Files for Hong Kong IPO
China-based Fujian Haixi Pharmaceuticals Co., Ltd., a commercial-stage innovative pharmaceutical company, has made an initial...
Servier and Google Cloud Extend Partnership to Advance AI in Drug Development
France-based Servier Group and US technology firm Google Cloud have announced an expansion to their...
Cathay Biotech Plans $901M Private Placement to Boost Bio-Based Materials
Shanghai-based Cathay Biotech Inc. (SHA: 688065) has announced plans to raise RMB 6.6 billion (USD...
Simcere Licenses Fermion’s AI-Enabled Painkiller FZ002-037
China-based Simcere Pharmaceutical Group Limited (HKG: 2096) has announced a licensing agreement with compatriot firm...
Bio-Thera Solutions Licenses BAT2206 to World Medicine for Turkey
On January 16, Bio-Thera Solutions Ltd (SHA: 688177), a science – driven innovative global biopharmaceutical...
GE Healthcare and Sutter Health Form $1B Care Alliance
US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) has formed...
Biogen Proposes to Acquire Sage Therapeutics for $469M
US-based Sage Therapeutics, Inc. (NASDAQ: SAGE) has announced that it received an unsolicited, nonbinding proposal...
Medtronic Secures Exclusive Distribution Rights for Contego’s Neuroguard and Excipio
US-Irish firm Medtronic (NYSE: MDT) has entered into an exclusive distribution agreement with Contego Medical,...
Eli Lilly to Acquire Scorpion Therapeutics’ STX-478 for $2.5B
US-based pharmaceutical giant Eli Lilly and Company (NYSE: LLY) is set to acquire STX-478 from...
Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6B
US-based Johnson & Johnson (J&J, NYSE: JNJ) is set to acquire all outstanding shares of...
GSK Acquires IDRx for $1B to Boost GIST Treatment Pipeline
UK-headquartered GlaxoSmithKline (GSK; NYSE: GSK) has entered into an agreement with US-based biopharma IDRx, Inc....
Autobio Diagnostics Partners with Boditech Med for Korean IVD Market
China-based Autobio Diagnostics Co., Ltd (SHA: 603658) has announced a strategic partnership with South Korea-headquartered...
Henlius and Abbott Sign License Agreement for Biosimilars and Biologic Drug
China-based Shanghai Henlius Biotech Inc. (HKG: 2696) has announced a strategic license agreement with Abbott...
Bristol-Myers Squibb Exercises License for ArsenalBio’s AB-4000 Series
US-based cell therapy company Arsenal Biosciences, Inc. has announced that Bristol-Myers Squibb (BMS, NYSE: BMY)...
Gentize Biopharma Raises $13.64M in Pre-Series A for Vaccine Development
Gentize Biopharma, a clinical-stage vaccine developer based in Nanjing, has reportedly raised close to RMB...
Illumina Partners with NVIDIA to Advance Multiomic Data Analysis
US-based genomics giant Illumina (NASDAQ: ILMN) has announced a strategic partnership with chip manufacturer NVIDIA...
Mediar Therapeutics and Eli Lilly Ink Deal for IPF Drug MTX-463
US-based clinical-stage biotech Mediar Therapeutics, Inc. has announced a global license agreement with Eli Lilly...